Compendium of Pharmaceuticals and Specialties

Last updated
CPS: Drug Information
Compendium of Pharmaceuticals and Specialties 2015 Print Edition.jpg
Author Canadian Pharmacists Association
CountryCanada
LanguageEnglish / French
Media typePrint / Online / Mobile

The Compendium of Pharmaceuticals and Specialties: The Canadian Drug Reference for Health Professionals, more commonly known by its abbreviation CPS, [1] is a reference book that contains drug monographs and numerous features which help healthcare professionals prescribe and use drugs safely and appropriately. A print version of CPS is released annually by the Canadian Pharmacists Association (CPhA). The CPhA is a nonprofit organization that advocates for pharmacists in Canada. An external Editorial Advisory Committee of Canadian physicians and pharmacists advises CPhA about the strategic direction of their publications including CPS. CPS is also available online by subscription at www.pharmacists.ca. Most of the drug monographs in CPS are provided by manufacturers, though numerous monographs—usually for drugs which are available as generic brands— are written by CPhA editorial staff and peer reviewed. 2010 marked the 50th anniversary of the first edition of CPS.

Contents

CPS Content

The following sections appear in CPS.

Brand and Generic Name Index

The Brand and Generic Name Index is located at the front of CPS. It is the most comprehensive list of current brand and generic drugs in Canada, and also includes discontinued products. This section is also referred to as the green section because of the green border on the right side of the pages.

Therapeutic Guide

The Therapeutic Guide is located near the front of CPS. These pages offer uses or indications and the drugs available to treat that indication. The Therapeutic Guide is also referred to as the pink section because of the pink border on the right side of the pages.

Product Identification

The Product Identification section includes photos and illustrations of numerous drugs in pill, tablet, caplet, capsule, syrup, and other forms. These illustrations and professional photos are included if manufacturers wish to participate in this service.

Clin-Info

The Clin-Info section is located at the front of CPS. Clin-Info provides clinically useful equations, principles of prescribing in pregnancy, drug and food administration, immunization schedules, and other quick reference information for healthcare professionals to safely and effectively use drugs. The Clin-Info section is also referred to as the lilac section because of the lilac border on the right side of the pages.

Directory

The Directory includes contact information for poison control centres, health organizations, and pharmaceutical manufacturers.

Monographs

There are two types of monographs that appear in CPS.

Product Monographs

The bulk of CPS consists of monographs that are provided by pharmaceutical manufacturers. These monographs are written and owned by the manufacturers and are approved by Health Canada. CPhA formats the monographs for publication but does not change the content of these monographs in any way. The section of the book that contains monographs is also referred to as the white section because of the lack of any coloured border on the right side of the pages. Monographs appear alphabetically by brand name.

CPhA Monographs

Amongst the manufacturer-supplied monographs in CPS are numerous monographs—200 in 2014— compiled by editorial staff at CPhA. These CPhA monographs are peer reviewed by Canadian experts, provide the best available evidence and accumulated clinical information about the drug or drug class. In addition, each CPhA monograph contains a section on pregnancy and breastfeeding. CPhA monographs are indexed at the front of CPS and easily identified—the titles are shaded in grey— throughout CPS.

Information for the Patient

Information for the Patient provides helpful advice and how-to information for patients on many drugs. This is Part III of the Health Canada approved product monograph and reflects the content of Part I, but is written in lay language that is easier for patients to understand. This section is only available in e-CPS.

Drug Updates

Drug updates about new molecular entities, new products, new indications, and new safety information are published in e-CPS and are also available at www.pharmacists.ca under the "products" tab. All updates appear in the subsequent print edition of CPS.

Appendices

The Appendices contain Health Canada drug regulatory and monitoring programs' reporting and request forms on such topics as Narcotic and Controlled Drugs, Benzodiazepines and Other Targeted Substances, and Adverse Events Following Immunization: Surveillance and Reporting.

Glossaries

A number of helpful glossaries appear near the end of CPS including Medical Abbreviations, and Latin Prescription Terms.

Other Information about CPS

The following sections include other information about CPS.

CPS Online

All the information that appears in the CPS print edition is also available to subscribers at https://cps.pharmacists.ca/. The information in CPS is updated every week or more frequently depending on the urgency of the information. Health Canada alerts are also added to the drug monographs in CPS when they are issued. Includes Lexi-Interact drug interaction checker.

Physical Description

The print version of CPS has a blue cover and perfect binding. The English edition is published as a two volume set. The page size is 9" 3/8 x 11" 7/8 and the font size is 6.5.

Release Date

The English version of CPS is released in January every year, and the French version is released in February every year.

History

2010 marked the 50th anniversary of the first publication of CPS (although not the 50th edition—there were some years in which CPS was not published). CPS has been published annually since 1967. There have been numerous changes and additions to CPS over the years including the first French edition in 1968, a move from hard-cover to soft-cover in 1981, and the introduction of e-CPS in 2004. With each passing year there are more drug monographs and information in CPS, which has resulted in a steadily increasing volume size. Sales have continued to grow as CPS remains the most comprehensive and frequently used reference for safely and accurately prescribing drugs in Canada.

Criticisms

In the past, the CPS has been criticized for being heavily influenced by the pharmaceutical industry and for lacking important information, such as efficacy and price. [2] Pharmaceuticals in the CPS are listed by their brand name, [3] as opposed to by the International Nonproprietary Name (INN) or United States Adopted Name (USAN).

Some have called for the creation of an independent, nonprofit organization to manage the CPS. [2]

Related Research Articles

<i>British National Formulary</i> Pharmaceutical reference book for the UK

The British National Formulary (BNF) is a United Kingdom (UK) pharmaceutical reference book that contains a wide spectrum of information and advice on prescribing and pharmacology, along with specific facts and details about many medicines available on the UK National Health Service (NHS). Information within the BNF includes indication(s), contraindications, side effects, doses, legal classification, names and prices of available proprietary and generic formulations, and any other notable points. Though it is a national formulary, it nevertheless also includes entries for some medicines which are not available under the NHS, and must be prescribed and/or purchased privately. A symbol clearly denotes such drugs in their entry.

<span class="mw-page-title-main">Over-the-counter drug</span> Medication available without a prescription

Over-the-counter (OTC) drugs are medicines sold directly to a consumer without a requirement for a prescription from a healthcare professional, as opposed to prescription drugs, which may be supplied only to consumers possessing a valid prescription. In many countries, OTC drugs are selected by a regulatory agency to ensure that they contain ingredients that are safe and effective when used without a physician's care. OTC drugs are usually regulated according to their active pharmaceutical ingredient (API) rather than final products. By regulating APIs instead of specific drug formulations, governments allow manufacturers the freedom to formulate ingredients, or combinations of ingredients, into proprietary mixtures.

<span class="mw-page-title-main">Pharmacist</span> Healthcare professional

A pharmacist, also known as a chemist or a druggist, is a healthcare professional who specializes in the preparation, dispensing, and management of medications to ensure safe and effective use, while also providing medication counseling and guidance to patients and healthcare providers. Also, pharmacists often serve as primary care providers in the community, and may offer other services such as health screenings and immunizations.

<span class="mw-page-title-main">Generic drug</span> Pharmaceutical equivalent to a brand-name product

A generic drug is a pharmaceutical drug that contains the same chemical substance as a drug that was originally protected by chemical patents. Generic drugs are allowed for sale after the patents on the original drugs expire. Because the active chemical substance is the same, the medical profile of generics is equivalent in performance. A generic drug has the same active pharmaceutical ingredient (API) as the original, but it may differ in some characteristics such as the manufacturing process, formulation, excipients, color, taste, and packaging.

<span class="mw-page-title-main">Pharmacy</span> Clinical health science

Pharmacy is the science and practice of discovering, producing, preparing, dispensing, reviewing and monitoring medications, aiming to ensure the safe, effective, and affordable use of medicines. It is a miscellaneous science as it links health sciences with pharmaceutical sciences and natural sciences. The professional practice is becoming more clinically oriented as most of the drugs are now manufactured by pharmaceutical industries. Based on the setting, pharmacy practice is either classified as community or institutional pharmacy. Providing direct patient care in the community of institutional pharmacies is considered clinical pharmacy.

<span class="mw-page-title-main">Prescription drug</span> Medication legally requiring a medical prescription before it can be dispensed

A prescription drug is a pharmaceutical drug that is permitted to be dispensed only to those with a medical prescription. In contrast, over-the-counter drugs can be obtained without a prescription. The reason for this difference in substance control is the potential scope of misuse, from drug abuse to practicing medicine without a license and without sufficient education. Different jurisdictions have different definitions of what constitutes a prescription drug.

The pregnancy category of a medication is an assessment of the risk of fetal injury due to the pharmaceutical, if it is used as directed by the mother during pregnancy. It does not include any risks conferred by pharmaceutical agents or their metabolites in breast milk.

<span class="mw-page-title-main">Dicycloverine</span> Antispasmodic agent

Dicycloverine, also known as dicyclomine, sold under the brand name Bentyl in the US, is a medication that is used to treat spasms of the intestines such as occur in irritable bowel syndrome. It is taken by mouth or by injection into a muscle. While it has been used in baby colic and enterocolitis, evidence does not support these uses.

The Pharmaceutical Benefits Scheme (PBS) is a program of the Australian Government that subsidises prescription medication for Australian citizens and permanent residents, as well as international visitors covered by a reciprocal health care agreement. The PBS is separate to the Medicare Benefits Schedule, a list of health care services that can be claimed under Medicare, Australia's universal health care insurance scheme.

The British Pharmacopoeia (BP) is the national pharmacopoeia of the United Kingdom. It is an annually published collection of quality standards for medicinal substances in the UK, which is used by individuals and organisations involved in pharmaceutical research, development, manufacture and testing.

<span class="mw-page-title-main">Tizanidine</span> Muscle relaxant medication

Tizanidine, sold under the brand name Zanaflex among others, is an alpha-2 (α2) adrenergic receptor agonist, similar to clonidine, that is used to treat muscle spasticity due to spinal cord injury, multiple sclerosis, and spastic cerebral palsy. Effectiveness appears similar to baclofen or diazepam. It is taken by mouth.

<i>British National Formulary for Children</i>

BNF for Children (BNFC) is the standard UK paediatric reference for prescribing and pharmacology.

<i>Martindale: The Complete Drug Reference</i>

Martindale: The Complete Drug Reference is a reference book published by Pharmaceutical Press listing some 6,000 drugs and medicines used throughout the world, including details of over 125,000 proprietary preparations. It also includes almost 700 disease treatment reviews.

<span class="mw-page-title-main">Compounding</span> Preparation of a custom medication

In the field of pharmacy, compounding is preparation of a custom medication to fit a unique need of a patient that cannot be met with commercially available products. This may be done for medical reasons, such as administration in a different format, to avoid a non-active ingredient the patient is allergic to, or to provide an exact dose that isn't commercially available. Patient-specific compounding according to a prescriber's specifications is referred to as "traditional" compounding. The nature of patient need for such customization can range from absolute necessity to individual optimality to even preference.

Pharmaceutical policy is a branch of health policy that deals with the development, provision and use of medications within a health care system. It embraces drugs, biologics, vaccines and natural health products.

<i>Monthly Index of Medical Specialities</i> Pharmaceutical prescribing reference guide

The Monthly Index of Medical Specialities or MIMS is a pharmaceutical prescribing reference guide published in the United Kingdom since 1959 by Haymarket Media Group. MIMS is also published internationally by various organisations, including in Australia, New Zealand, China, Hong Kong, India, Indonesia, Japan, Korea, Malaysia, Myanmar, the Philippines, Singapore, Thailand, and Vietnam.

A formulary is a list of pharmaceutical drugs, often decided upon by a group of people, for various reasons such as insurance coverage or use at a medical facility. Traditionally, a formulary contained a collection of formulas for the compounding and testing of medication. Today, the main function of a prescription formulary is to specify particular medications that are approved to be prescribed at a particular hospital, in a particular health system, or under a particular health insurance policy. The development of prescription formularies is based on evaluations of efficacy, safety, and cost-effectiveness of drugs.

The Canadian Pharmacists Association (CPhA), previously known as the Canadian Pharmaceutical Association, is an organization that serves as the professional association of Canadian pharmacists and pharmacy students. It was founded in 1907 in Toronto, Ontario. In 2014, CPhA adopted a new governance and membership model, most provincial pharmacy advocacy associations (PPAs) and select national pharmacist associations (NPAs) have become Organizational Members of CPhA. Their individual pharmacist and pharmacy student members are now CPhA Associates. The CPhA Board of Directors is made up of representatives appointed by each Organizational Member. The Board of Directors is responsible for setting the broad direction of the association.

<i>Irish Medicines Formulary</i>

Irish Medicines Formulary (IMF) is a medicines reference for doctors, nurses, pharmacists and dentists, providing medicines information which is medico-legally relevant in Ireland. It is published in online and print formats, and lists original brands, branded generics and pure generic prescription medicines.

Dr Jean Gray is a Canadian academic and retired physician, who is professor emeritus of medical education, medicine and pharmacology at Dalhousie University. She has served as president of the Canadian and American Society of Clinical Pharmacology. She was invested as a Member of the Order of Canada in 2005, and has been a Fellow of the Royal College of Physicians since 2007. She was inducted into the Canadian Medical Hall of Fame in 2020.

References

  1. Repchinsky, C (2002). "The CPS: love, hate and expectations". The Canadian Journal of Clinical Pharmacology. 9 (2): 62–3. PMID   12172584.
  2. 1 2 Bell RW, Osterman JW (1983). "The Compendium of Pharmaceuticals and Specialties: a critical analysis". International Journal of Health Services. 13 (1): 107–18. doi:10.2190/RMQL-RQ29-WGHK-7V5J. PMID   6832868. S2CID   26493985.
  3. Guide to the Compendium of Pharmaceuticals and Specialties (CPS). College of Pharmacists of British Columbia. Available at: http://bcpharmacists.org/professionaldevelopment/toolkit/CPS.htm Archived 2006-12-20 at the Wayback Machine . Accessed on: December 22, 2006.